D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Genetics and Molecular Biology D-index 41 Citations 17,094 71 World Ranking 4966 National Ranking 54

Overview

What is she best known for?

The fields of study she is best known for:

  • Gene
  • Cancer
  • DNA

Her main research concerns Mutation, Cancer research, Genetics, Melanoma and P110α. Her Mutation study incorporates themes from Caenorhabditis elegans, Carcinogenesis, Downregulation and upregulation, Kinase activity and PI3K/AKT/mTOR pathway. Her Cancer research research incorporates elements of Gene, Kinase and PTEN.

Her work on Mutant and Cell cycle as part of general Genetics study is frequently linked to Cohesin complex, Chromosome instability and Chromatid, therefore connecting diverse disciplines of science. Her study in Melanoma is interdisciplinary in nature, drawing from both Cancer, Epitope, Immunology, Antigen and Adoptive cell transfer. She has researched Cancer in several fields, including Signal transduction and Bioinformatics.

Her most cited work include:

  • High frequency of mutations of the PIK3CA gene in human cancers (2829 citations)
  • Genomic Classification of Cutaneous Melanoma (1491 citations)
  • Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells (741 citations)

What are the main themes of her work throughout her whole career to date?

Her scientific interests lie mostly in Cancer research, Melanoma, Mutation, Cancer and Genetics. Her work deals with themes such as Cell growth, Somatic cell, Mutant, Signal transduction and Tumor suppressor gene, which intersect with Cancer research. Her Melanoma research includes themes of Immunology, Antigen, Metastasis, Neuroblastoma RAS viral oncogene homolog and Nonsense mutation.

Her research investigates the connection with Mutation and areas like P110α which intersect with concerns in Oncogene. Her research integrates issues of Exome sequencing, Exome, Computational biology and Bioinformatics in her study of Cancer. In general Genetics study, her work on PI3K/AKT/mTOR pathway, Germline mutation, Repressor and Regulation of gene expression often relates to the realm of Synonymous substitution, thereby connecting several areas of interest.

She most often published in these fields:

  • Cancer research (57.89%)
  • Melanoma (50.38%)
  • Mutation (37.59%)

What were the highlights of her more recent work (between 2018-2021)?

  • Cancer research (57.89%)
  • Melanoma (50.38%)
  • Immune system (4.51%)

In recent papers she was focusing on the following fields of study:

Yardena Samuels mostly deals with Cancer research, Melanoma, Immune system, Neuroblastoma RAS viral oncogene homolog and Human leukocyte antigen. Yardena Samuels has included themes like Cell, Trametinib, MAPK/ERK pathway, Nonsense mutation and Antigen presentation in her Cancer research study. Her research in Melanoma is mostly concerned with Cutaneous melanoma.

Her Neuroblastoma RAS viral oncogene homolog research is within the category of Mutation. She works mostly in the field of Human leukocyte antigen, limiting it down to concerns involving Major histocompatibility complex and, occasionally, Computational biology, Cancer immunology and Adoptive cell transfer. Her work in Cancer addresses subjects such as Protein kinase domain, which are connected to disciplines such as Signal transduction.

Between 2018 and 2021, her most popular works were:

  • UVB-Induced Tumor Heterogeneity Diminishes Immune Response in Melanoma (97 citations)
  • PIK3CA in cancer: The past 30 years. (40 citations)
  • Cross-Talk between Receptor Tyrosine Kinases AXL and ERBB3 Regulates Invadopodia Formation in Melanoma Cells (19 citations)

In her most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

Her primary areas of study are Cancer research, Immune system, Melanoma, Antigen presentation and Human leukocyte antigen. A large part of her Cancer research studies is devoted to Melanoma patient. As part of her studies on Immune system, Yardena Samuels often connects relevant subjects like Clonal diversity.

The study incorporates disciplines such as Intracellular parasite, Tumor-infiltrating lymphocytes, Immunotherapy, PSMB8 and Antigen in addition to Antigen presentation. The concepts of her Human leukocyte antigen study are interwoven with issues in Intracellular and Bacteria.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

High frequency of mutations of the PIK3CA gene in human cancers

Yardena Samuels;Zhenghe Wang;Alberto Bardelli;Natalie Silliman.
Science (2004)

3782 Citations

Genomic Classification of Cutaneous Melanoma

Rehan Akbani;Kadir C. Akdemir;B. Arman Aksoy;Monique Albert.
Cell (2015)

1552 Citations

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

Yardena Samuels;Luis A. Diaz;Oleg Schmidt-Kittler;Jordan M. Cummins.
Cancer Cell (2005)

955 Citations

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

Paul F. Robbins;Yong Chen Lu;Mona El-Gamil;Yong F. Li.
Nature Medicine (2013)

915 Citations

The PIK3CA gene is mutated with high frequency in human breast cancers

Kurtis E. Bachman;Pedram Argani;Yardena Samuels;Natalie Silliman.
Cancer Biology & Therapy (2004)

794 Citations

Oncogenic PI3K and its role in cancer.

Yardena Samuels;Kajsa Ericson.
Current Opinion in Oncology (2006)

615 Citations

The Structure of a Human p110α/p85α Complex Elucidates the Effects of Oncogenic PI3Kα Mutations

Chuan Hsiang Huang;Diana Mandelker;Oleg Schmidt-Kittler;Yardena Samuels;Yardena Samuels.
Science (2007)

560 Citations

Colorectal cancer: mutations in a signalling pathway.

D. Williams Parsons;Tian Li Wang;Yardena Samuels;Alberto Bardelli;Alberto Bardelli.
Nature (2005)

534 Citations

Exome sequencing identifies GRIN2A as frequently mutated in melanoma

Xiaomu Wei;Vijay Walia;Jimmy C Lin;Jamie K Teer.
Nature Genetics (2011)

522 Citations

Oncogenic Mutations of PIK3CA in Human Cancers

Yardena Samuels;Victor E. Velculescu.
Cell Cycle (2004)

514 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Yardena Samuels

Richard A. Scolyer

Richard A. Scolyer

Royal Prince Alfred Hospital

Publications: 84

Gordon B. Mills

Gordon B. Mills

Oregon Health & Science University

Publications: 71

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 56

Georgina V. Long

Georgina V. Long

University of Sydney

Publications: 55

Xin Lu

Xin Lu

Ludwig Cancer Research

Publications: 50

John F. Thompson

John F. Thompson

University of Sydney

Publications: 49

Nicholas K. Hayward

Nicholas K. Hayward

QIMR Berghofer Medical Research Institute

Publications: 49

Michael A. Davies

Michael A. Davies

The University of Texas MD Anderson Cancer Center

Publications: 48

Matthew Meyerson

Matthew Meyerson

Harvard University

Publications: 47

Levi A. Garraway

Levi A. Garraway

Harvard University

Publications: 46

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 46

Bert Vogelstein

Bert Vogelstein

Johns Hopkins University

Publications: 46

Keith T. Flaherty

Keith T. Flaherty

Harvard University

Publications: 43

Lewis C. Cantley

Lewis C. Cantley

Cornell University

Publications: 42

Reinhard Dummer

Reinhard Dummer

University of Zurich

Publications: 42

José Baselga

José Baselga

Memorial Sloan Kettering Cancer Center

Publications: 39

Trending Scientists

Pat Langley

Pat Langley

Stanford University

Danny Sutanto

Danny Sutanto

University of Wollongong

Debora Fino

Debora Fino

Polytechnic University of Turin

Philip A. Parker

Philip A. Parker

University of New Brunswick

Jianbo Shi

Jianbo Shi

Chinese Academy of Sciences

Edith Heard

Edith Heard

European Bioinformatics Institute

Alison Baker

Alison Baker

University of Leeds

Martin Holmstrup

Martin Holmstrup

Aarhus University

Henrik Nielsen

Henrik Nielsen

Technical University of Denmark

Brian Jones

Brian Jones

University of Alberta

Marta E Torres

Marta E Torres

Oregon State University

Richard Atkinson

Richard Atkinson

St George's, University of London

J. Tuomilehto

J. Tuomilehto

Finnish Institute for Health and Welfare

Cynthia E. Dunbar

Cynthia E. Dunbar

National Institutes of Health

Thomas J. Beckman

Thomas J. Beckman

Mayo Clinic

P. D. Grannis

P. D. Grannis

Stony Brook University

Something went wrong. Please try again later.